XEN-901

N/A

Report date: 2026/05/28 20:00:21
NME

Base Information

Drug NameXEN-901
Drug Alias NameXEN-901NBI-921352
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSodium channel protein type VIII alpha subunit blockers
TargetsSodium channel protein type VIII alpha subunit
Therapy Area/IndicationsEpilepsies, PartialEpilepsyBrain Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaBelgiumUnited States +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesXenon Pharma
China Registration ClassN/A

Develop Information

Active CompaniesNeurocrine Biosciences Inc
Inactive CompaniesN/A
Active IndicationsEpilepsies, PartialEpilepsy
Inactive IndicationsBrain Diseases

Other Information

ATC CodeN/A
Related LinksN/A